Jci_page_head_homepage_01 Jci_page_head_homepage_02
Punita Dhawan, Amar B. Singh, Natasha G. Deane, YiRan No, Sheng-Ru Shiou, Carl Schmidt, John Neff, M. Kay Washington, R. Daniel Beauchamp
Published in Volume 115, Issue 7
J Clin Invest. 2005; 115(7):1765–1776 doi:10.1172/JCI24543
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 5

Effect of modulation of claudin-1 expression on tumor xenograft and liver metastasis in vivo. (A) Flank tumor xenografts after subcutaneous injection (n = 5 mice per group) were monitored for SW480control or 2 individual SW480claudin-1 clones in nude mice (*P < 0.005 and P = 0.063 for each clone compared with the control group). Conversely, cells expressing either SW620control or 2 individual SW620siRNA clones in nude mice were used (P = 0.27 and P = 0.26). The P value was determined using unpaired Student’s t test. (BG) Liver metastasis. Representative metastatic tumors in livers from SW480control (B) and SW480claudin-1 cells (CE) from experiments on nude mice, with corresponding H&E sections indicating intrahepatic tumors (F and G), are shown. (F) Microscopic examination of the liver tumors confirmed that they represented metastases. (G) Intrahepatic vascular spread was noted. (HK) SW620 parental or SW620control cells or 3 individual SW620siRNA clones were injected in nude mice. Seven weeks after inoculation, metastatic tumors were detected in the livers of nude mice by microPET (H and I) and upon necroscopy (J and K). MicroPET imaging was used to screen for nonpalpable lesions in the liver, using 100–150 μCi of 18F-deoxyglucose (18FDG) injected i.p to detect metabolically active foci in the abdomen. The arrows point to the metastatic nodules in the liver. The P value was determined using 2-sided test of proportion.